Security key
90138K101
20/20 Biolabs, Inc. - Common Stock, par value $0.01 (AIDX)
CUSIP: 90138K101
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.01
- Total 13F shares
- 540,620
- Total 13F value
- $297,121
- Share change
- +240,195
- SEC-reported price per share
- $0.55
- Number of holders
- 15
- Value change
- +$115,933
- Number of buys
- 12
- Number of sells
- 5
- Shares outstanding
- 10,340,714
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
15
Top holders
10
AIDX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
20/20 Biolabs, Inc. SEC filings
20/20 Biolabs, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90138K101
Recent filing periods:
Ownership snapshot
Top reported holders of AIDX - 20/20 Biolabs, Inc. - Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jonathan M. Cohen
Disclosed value leader
Cresset Asset Management,...
Comparable rows
10/15
Latest evidence
02 Apr 2026
3/4/5
13D/G
13F
Lead comparable stake: 17%
5 rows are not safely comparable across share classes.
13D/G row: Jonathan M. Cohen
Showing 1-6 of 15 holder rows.
Quick read
Jonathan M. Cohen leads the comparable SEC ownership view at 17%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jonathan M. Cohen's linked filing trail.
Comparable ownership
Top 5
Jonathan M. Cohen
17%
Streeterville Capital LLC
9.9%
Full Succeed International Ltd
6.3%
Cresset Asset Management, LLC
2.6%
CITADEL ADVISORS LLC
0.16%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jonathan M. Cohen |
3/4/5
13D/G
Chief Executive Officer, Director, 10%+ Owner
|
17%
from 13D/G
|
—
1,719,336 shares
mixed-class rows
|
— | 03 Mar 2026 |
| Streeterville Capital LLC |
13D/G
|
9.9%
|
—
543,680 shares
|
$0 | 25 Feb 2026 |
| Full Succeed International Ltd |
13D/G
Full Succeed International Limited
|
6.3%
|
—
651,465 shares
|
$0 | 19 Feb 2026 |
| Cresset Asset Management, LLC |
13F
Company
|
2.6%
|
$497,012
264,368 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.16%
|
$30,507
16,227 shares
|
— | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
0.1%
|
$19,419
10,329 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
540,620
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
7
Q2 2026 holders
15
Holder diff
8
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend